| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |